Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2017 2
2018 4
2019 4
2020 2
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.
Hamilton BK, Rybicki LA, Li H, Lucas T, Corrigan D, Kalaycio M, Sobecks R, Hanna R, Rotz SJ, Dean RM, Gerds AT, Jagadeesh D, Brunstein C, Sauter CS, Copelan EA, Majhail NS. Hamilton BK, et al. Among authors: corrigan d. Blood Adv. 2023 Aug 22;7(16):4505-4513. doi: 10.1182/bloodadvances.2023010310. Blood Adv. 2023. PMID: 37352262 Free PMC article. Clinical Trial.
Evaluation of pre-transplant risk assessments in allogeneic hematopoietic cell transplant.
Hegde PS, Rybicki L, Serafino S, Bernhard L, Corrigan D, Anwer F, Kalaycio M, Sobecks RM, Jagadeesh D, Hill BT, Dean RM, Khouri J, Winter AM, Pohlman B, Majhail NS, Hamilton BK. Hegde PS, et al. Among authors: corrigan d. Bone Marrow Transplant. 2022 Jun;57(6):1031-1033. doi: 10.1038/s41409-022-01677-8. Epub 2022 Apr 15. Bone Marrow Transplant. 2022. PMID: 35428866 No abstract available.
Day 100 risk assessment tool predicts overall survival in allogeneic hematopoietic cell transplantation.
Hegde P, Rybicki L, Serafino S, Ferraro C, Kalaycio M, Sobecks R, Gerds AT, Caroniti S, Corrigan D, Giannetti K, Elberson J, Hodgeman B, Starn J, Dabney J, McLellan L, Majhail NS, Hamilton BK. Hegde P, et al. Among authors: corrigan d. Bone Marrow Transplant. 2022 Jan;57(1):131-133. doi: 10.1038/s41409-021-01491-8. Epub 2021 Oct 9. Bone Marrow Transplant. 2022. PMID: 34628474 No abstract available.
Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Hamilton BK, Rybicki LA, Grove D, Ferraro C, Starn J, Hodgeman B, Elberson J, Winslow V, Corrigan D, Gerds AT, Hanna R, Kalaycio ME, Sobecks RM, Majhail NS, Dweik RA. Hamilton BK, et al. Among authors: corrigan d. Blood Adv. 2019 Sep 24;3(18):2732-2737. doi: 10.1182/bloodadvances.2019000345. Blood Adv. 2019. PMID: 31530545 Free PMC article.
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit-positive Acute Myeloid Leukemia.
Advani AS, Tse W, Li H, Jia X, Elson P, Cooper B, Ali-Osman F, Park J, Rao AV, Rizzieri DA, Wang ES, Cotta CV, Kalaycio M, Sobecks RM, Rouphail B, Maciejewski JP, Fensterl J, Carew JS, Foster B, Rush ML, Tripp B, Adams D, Corrigan D, Griffiths EA, Sekeres MA. Advani AS, et al. Among authors: corrigan d. Clin Lymphoma Myeloma Leuk. 2021 Feb;21(2):113-118. doi: 10.1016/j.clml.2020.11.018. Epub 2020 Dec 3. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33422470 Clinical Trial.
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation.
Patel SS, Rybicki LA, Corrigan D, Bolwell B, Dean R, Liu H, Gerds AT, Hanna R, Hill B, Jagadeesh D, Kalaycio M, Pohlman B, Sobecks R, Majhail NS, Hamilton BK. Patel SS, et al. Among authors: corrigan d. Biol Blood Marrow Transplant. 2018 May;24(5):1029-1034. doi: 10.1016/j.bbmt.2018.01.016. Epub 2018 Jan 31. Biol Blood Marrow Transplant. 2018. PMID: 29369800 Free PMC article.
Low-Dose Lenalidomide After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation With Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma.
Khouri J, Reu F, Majhail NS, Gerds A, Jagadeesh D, Dean R, Sobecks R, Hamilton BK, Pohlman B, Hill BT, Corrigan D, Kalaycio M, Bolwell BJ, Liu HD. Khouri J, et al. Among authors: corrigan d. Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e374-e376. doi: 10.1016/j.clml.2019.03.019. Epub 2019 Apr 8. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31053548 No abstract available.
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era.
Hong S, Rybicki L, Corrigan D, Hamilton BK, Sobecks R, Kalaycio M, Gerds AT, Dean RM, Hill BT, Pohlman B, Jagadeesh D, Anwer F, Majhail NS. Hong S, et al. Among authors: corrigan d. Hematol Oncol Stem Cell Ther. 2021 Dec;14(4):318-326. doi: 10.1016/j.hemonc.2020.11.006. Epub 2020 Dec 5. Hematol Oncol Stem Cell Ther. 2021. PMID: 33301747 Free article.
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation.
Patel SS, Rybicki LA, Corrigan D, Dumont C, Bolwell B, Dean R, Figueroa P, Hanna R, Liu H, Gerds AT, Hill B, Jagadeesh D, Kalaycio M, Pohlman B, Ricci K, Sobecks R, Lu W, Hamilton BK, Majhail NS. Patel SS, et al. Among authors: corrigan d. Bone Marrow Transplant. 2019 May;54(5):775-781. doi: 10.1038/s41409-018-0380-5. Epub 2018 Oct 30. Bone Marrow Transplant. 2019. PMID: 30375493 Clinical Trial.
15 results